Lp(a) jako czynnik sprzyjający rozwojowi choroby wieńcowej serca

• Autorzy: Nowicka G.

Warianty tytułu

EN

Lp(a) as promoting factor of ischaemic heart disease

• Języki publikacji: PL

Słowa kluczowe

PL

choroby serca; miazdzyca; choroby czlowieka; zywienie czlowieka; ryzyko zachorowan; czynniki chorobotworcze; lipoproteiny; apolipoproteiny; uwarunkowania genetyczne

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 1990
• Tom: 17
• Numer: 1
• Opis fizyczny: s.70-75,bibliogr.

Twórcy

autor

Nowicka G.

• Zakład Żywienia Klinicznego, Instytut Żywności i Żywienia w Warszawie, Warszawa

Bibliografia

• 1. Albers J. J., Adolphson J. L, Hazzard W. R.: Radioimmunoassay of human Lp(a) lipoprotein. J. Lipid Res., 1977, 18, 331.
• 2. Albers J. J., Cabana V. G., Warnick G.R. et al.: Lp(a) lipoprotein: relationship to sinking pre- lipoprotein, hyperlipoproteinemia and apolipoprotein B. Metabolism 1975, 24, 1047.
• 3. Armstrong V. W., Eberle E., Cremer P.: The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986, 62, 249.
• 4. Armstrong V. W., Walli A. U., Seidel D.: Isolation, characterization and uptake in human fibroblasts of an apo(a) - free lipoprotein obtained on reduction of lipoprotein (a). J. Lipid Res., 1985, 26, 1314.
• 5. Berg K.: A new serum type system in man - the Lp(a) system. Acta Pathol. Microbiol. Scand., 1963, 59, 369.
• 6. Berg K.: Inherited lipoprotein variations and atherosclerotic disease. In: The biochemistry of atherosclerosis. Ed: A. M. Scanu. New York, 1979, p. 419.
• 7. Bersot T. P., Innerarity T. L., Pitas R. W. et al.: Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein (a) and that cause lipid accumulation in macrophages. J. Clin. Invest., 1986, 77, 622.
• 8. Chapman M. J., Laplaud P. M., Luc G. et al.: Further resolution of the low density lipoprotein spectrum in normal plasma: physico-chemical characteristics of disxrete subspecies separated by density gradient ultracentrifugation. J. Lipid Res., 29, 442.
• 9. Cushing G. L., Gaubatz J. W., Burdick B. J. et al.: Localization and quantitation of apolipoprotein (a) and B in coronary artery bypass vein grafts resected at operation. Arteriosclerosis 1986, 6, 555a.
• 10. Dahlen G. H., Guyton J. R., Attar M. et al.: Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986, 74, 758.
• 11. Fless G. M., Rolih C. A., Scanu A. M.: Heterogenity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J. Biol. Chem., 1984, 259, 11470.
• 12. Fless G. M., Zum Mallen M. E., Scanu A. M.: Physiochemical properties of apolipoprotein (a) and lipoprotein (a-) derived from the dissociation of human plasma lipoprotein (a). J. Biol. Chem., 1986, 261, 8712.
• 13. Fless G. M., Zum Mallen M. E., Scanu A. M.: Heterogeneity of human plasma Lp(a). In: Workshop on lipoprotein heterogeneity. Ed: U. Lippel. National Institutes of Health, Bethesda, MD, 1987, p. 141.
• 14. Gaubatz J. W., Cushing G. L., Morriseft J. D.: Quantitation, isolation and characterization of human Lp(a). Methods in Enzymology 1986, 129, 167.
• 15. Guraker A., Hoeg J. M, Kostner B. M. et al.: Levels of lipoprotein Lp(a) decline with Neomycin and Niacin treatment. Atherosclerosis 1985, 57, 293.
• 16. Guyton J. R., Dahlen G. H., Patsch W. et al.:Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B.Arteriosclerosis 1985, 5, 265.
• 17. Hoefler G., Harnoncourt F., Paschke E. et al.: Lipoprotein Lp(a) a risk factor for myocardial infarction. Arteriosclerosis 1988, 8, 398.
• 18. Hoff H. F., Beck G. J., Skibiński C. I. et al.: Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988, 77, 1238.
• 19. Jürgens G., Költringer P.: Lipoprotein (a) in ischemic cerebrovascular disease: new approach to the assessment of risk for stroke. Neurology 1987, 37, 513.
• 20. Karadi I., Kostner G. M., Gries A. et al.: Lipoprotein (a) and plasminogen are immunochemically related. Biochim. Biophys. Acta 1988, 960, 91.
• 21. Kostner G., Avogaro P., Cazzolato G. et al.: Lipoprotein Lp(a) and the risk for myocardial infarction Atherosclerosis 1981, 38, 51.
• 22. Kostner G. M., Varga M. B., Rotheneder M. et al.: Interaction of lipoprotein (a) with glycoso- aminoglycans. Possible mechanism for its atherogenicity. Arteriosclerosis 1986, 6, 522a.
• 23. Krempler F., Kostner G. M, Bolzano K. et al.: Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein B. Biochim. Biophys. Acta 1979, 575, 63.
• 24. Krempler F., Kostner G. M., Bolzano K. et al.: Turnover of lipoprotein (a). J. Clin. Invest., 1980, 65, 1483.
• 25. Krempler F., Kostner G. M., Roscher A. et al.: Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J. Clin. Invest., 1983, 71, 1432.
• 26. Malloy M. J., Kane J. P., Hardman A. et al.: Normotriglyceridemic abetalipoproteinemia. J. Clin. Invest., 1981, 67, 1441.
• 27. McLean J. W., Tomknson J. E., Kuang W. Y. et al.: cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987, 300, 132.
• 28. Renninger W., Wendt G. G., Nawrocki P. et al.: Beitrag zur Problematik des Lp-systems. Humangenetik 1965, 1, 658.
• 29. Scanu A. M.: Lipoprotein (a): genetically determined lipoprotein containing a glycoprotein of the plasminogen family. Seminars in Thrombosis and Hemostasis 1988, 14, 266.
• 30. Uterman G., Menzel H. J., Kraft H.G. et al.: Lp(a) glycoprotein phenotypes. J. Clin. Invest., 1987, 80, 458.
• 31. Uterman G., Weber W.: Protein composition of Lp(a) lipoprotein from human plasma. FFBS Lett., 1983, 154, 357.
• 32. Vessby G., Kostner G.M., Lithell H. et al.: Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). Atherosclerosis 1982, 44, 61.
• 33. Zenker G., Koeltringer P., Bone G.: Lipoprotein Lp(a) as a strong indicator for cerebrovascular disease. Stroke 1986, 17, 942.